'This is a special issue on 'AI in Pharma'. Articles in this issue explore how AI-driven technologies are accelerating drug discovery processes, enhancing precision in clinical trials, and enabling personalised medicine.'
The pharmaceutical industry is on the verge of a technological revolution catalysed by Artificial Intelligence AI
AI is currently being employed in various ways throughout clinical research
As our industry stands on the verge of a revolution enabled by artificial intelligence AI the future belongs to those who can see a world that doesnt yet exist
Drug development stands at a pivotal juncture struggling with the challenges of slow progress and soaring costs
The pharmaceutical industry is undergoing a significant transformation by adapting machine learning ML and artificial intelligence AI technologies
The integration of artificial intelligence AI predictive models in drug discovery and development demands a thoughtful examination
Navigating the drug development pathway is akin to embarking on an expedition through uncharted territories
In the intricate realm of drug development where innovation stands as the cornerstone of human wellbeing the journey from discovery to market is a labyrinthine path fraught with challenges
From my vantage point over the past year the initial hype as well as the wariness around GenAI has started to settle into cautious optimism
The pharmaceutical industry faces rising costs stagnant innovation and growing demand for personalised medicine
The healthcare industry is undergoing a significant shift towards the adoption of precision medicine
The drug development process from discovery to market is an overly complex inefficient lengthy
The biology of disease can be confounding While some singlesource diseases can be accurately predicted
The th edition of MEDICAL FAIR ASIA and th edition of MEDICAL MANUFACTURING ASIA the regions leading specialist trade fairs
